Over the last few years, Gilead Sciences has grown into one of the world’s largest pharmaceutical companies, fueled by the sales of expensive specialty treatments for hepatitis C. The company’s revenue has tripled since 2012, to $32.6 billion last year.
Democracy Dies in Darkness
The drug company that shocked the world with its prices dodged $10 billion in taxes, report says
By Renae Merle
and July 13, 2016 at 6:00 a.m. EDT